Literature DB >> 26099844

Dyslipidaemia: Promising results for TA-8995 in TULIP.

Bryony M Mearns.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26099844     DOI： 10.1038/nrcardio.2015.97

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial.

Authors:  G Kees Hovingh; John J P Kastelein; Sander J H van Deventer; Patrick Round; John Ford; Danish Saleheen; Daniel J Rader; H Bryan Brewer; Philip J Barter
Journal:  Lancet       Date:  2015-06-02       Impact factor: 79.321
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.